Parallax Volatility Advisers, L.P. Astrazeneca PLC Transaction History
Parallax Volatility Advisers, L.P.
- $35.7 Billion
- Q1 2025
A detailed history of Parallax Volatility Advisers, L.P. transactions in Astrazeneca PLC stock. As of the latest transaction made, Parallax Volatility Advisers, L.P. holds 3 shares of AZN stock, worth $217. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3
Previous 45,460
99.99%
Holding current value
$217
Previous $2.98 Million
100.0%
% of portfolio
0.0%
Previous 0.01%
Shares
19 transactions
Others Institutions Holding AZN
# of Institutions
1,428Shares Held
504MCall Options Held
10MPut Options Held
3.14M-
Price T Rowe Associates Inc Baltimore, MD57.1MShares$4.13 Billion0.52% of portfolio
-
Primecap Management CO Pasadena, CA40.7MShares$2.94 Billion2.53% of portfolio
-
Wellington Management Group LLP Boston, MA35.6MShares$2.58 Billion0.52% of portfolio
-
Bank Of America Corp Charlotte, NC31.8MShares$2.3 Billion0.19% of portfolio
-
Capital International Investors Los Angeles, CA31.3MShares$2.26 Billion0.47% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $224B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...